Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Renal Manifestations”

271 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 271 results

Post-approval studies (Phase 4)Study completedNCT03047278
What this trial is testing

Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.

Who this might be right for
Neuropathic PainType 2 Diabetes MellitusDiabetic Neuropathy, Painful
Natalia Valadares de Moraes 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT06068439
What this trial is testing

Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy Type 2
Second Affiliated Hospital, School of Medicine, Zhejiang University 355
Testing effectiveness (Phase 2)UnknownNCT05718375
What this trial is testing

Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

Who this might be right for
Diabetic Nephropathies
Curacle Co., Ltd. 240
Testing effectiveness (Phase 2)Study completedNCT02345057
What this trial is testing

Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria

Who this might be right for
Diabetic Nephropathy
Daiichi Sankyo 365
Post-approval studies (Phase 4)Ended earlyNCT00961207
What this trial is testing

Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients

Who this might be right for
MicroalbuminuriaMacroalbuminuric Diabetic NephropathyDiabetes+2 more
Cook County Health 2
Early research (Phase 1)Ended earlyNCT01488877
What this trial is testing

Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

Who this might be right for
Type 2 Diabetic Nephropathy
Pfizer 6
Not applicableNot Yet RecruitingNCT07169422
What this trial is testing

Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care

Who this might be right for
Diabetic Kidney DiseaseType 2 DiabetesChronic Kidney Disease
Nova Scotia Health Authority 120
Post-approval studies (Phase 4)Looking for participantsNCT05390892
What this trial is testing

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Who this might be right for
Type2DiabetesASCVD
Brigham and Women's Hospital 6,000
Large-scale testing (Phase 3)Study completedNCT03436693
What this trial is testing

Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 308
Testing effectiveness (Phase 2)Study completedNCT01667614
What this trial is testing

Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure

Who this might be right for
Type 2 Diabetes MellitusDiabetic NephropathyEssential Hypertension
Tehran University of Medical Sciences 136
Large-scale testing (Phase 3)Study completedNCT00004266
What this trial is testing

Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes

Who this might be right for
Diabetic Nephropathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 160
Testing effectiveness (Phase 2)Looking for participantsNCT07396155
What this trial is testing

Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial

Who this might be right for
Diabetic Nephropathy Type 2
PT. Prodia Stem Cell Indonesia 10
Not applicableLooking for participantsNCT06376240
What this trial is testing

The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesMicrovascular FunctionRetinopathy, Diabetic+2 more
Maastricht University Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT03449199
What this trial is testing

Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria

Who this might be right for
Diabetic Kidney Disease
Teijin America, Inc. 130
Very early researchUnknownNCT03009864
What this trial is testing

The Multi-Center Clinical Study of Tang Shen Prescription on Type 2 Diabetic Kidney Disease in Early Stage

Who this might be right for
Diabetic Kidney Disease
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 632
Large-scale testing (Phase 3)Ended earlyNCT00555217
What this trial is testing

VA NEPHRON-D: Diabetes iN Nephropathy Study

Who this might be right for
Kidney DiseaseNephropathyType 2 Diabetes
US Department of Veterans Affairs 1,448
Not applicableUnknownNCT01215994
What this trial is testing

Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes MellitusDiabetic Nephropathy
AHEPA University Hospital 600
Large-scale testing (Phase 3)WithdrawnNCT03105219
What this trial is testing

IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease

Who this might be right for
Diabetic Kidney Disease
Nanjing First Hospital, Nanjing Medical University
Not applicableUnknownNCT06097351
What this trial is testing

Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value

Who this might be right for
Diabetic Nephropathy
Yipeng Liu 44
Post-approval studies (Phase 4)Study completedNCT00153023
What this trial is testing

1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy

Who this might be right for
Diabetic NephropathiesHypertension
Boehringer Ingelheim 885
Load More Results